Bora to discuss a recent collaboration with Therapi AI, highlighting its focus on strengthening operational execution across the biopharma development cycle and supply chain through AI-enabled technologies
HONG KONG SAR -
Media OutReach Newswire - 9 February 2026 - Bora Pharmaceuticals (Taiwan Stock Exchange: 6472.TW; OTCQX: BORAY), a pharmaceutical services company operating under a differentiated “Dual-Engine” strategy that integrates a global contract development and manufacturing organization (CDMO) with an innovative specialty pharmaceuticals business, announces its sponsorship of UC Berkeley ahead of the "Berkeley Dialogue” in Taipei.
Read more: Bora Pharmaceuticals to Sponsor "Berkeley Dialogue" in Taipei, Advancing the Biopharma R&D and...